
Inogen INGN
$ 6.49
-0.76%
Quarterly report 2026-Q1
added 05-08-2026
Inogen Total Liabilities 2011-2026 | INGN
Annual Total Liabilities Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106 M | 122 M | 121 M | 108 M | 119 M | 112 M | 103 M | 65.5 M | 48 M | 32 M | 27.3 M | 21.9 M | 26.1 M | 19 M | 16.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 122 M | 16.6 M | 69.9 M |
Quarterly Total Liabilities Inogen
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 M | 110 M | 113 M | 110 M | 122 M | 121 M | 121 M | 124 M | 121 M | 113 M | 99.6 M | 104 M | 108 M | 119 M | - | 116 M | 119 M | 122 M | 127 M | 120 M | 112 M | 112 M | 112 M | 112 M | 103 M | 103 M | 103 M | 103 M | 65.5 M | 65.5 M | 65.5 M | 65.5 M | 48 M | 48 M | 48 M | 48 M | 32 M | 32 M | 32 M | 32 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 26.1 M | 26.1 M | 26.1 M | 26.1 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 127 M | 21.9 M | 77.2 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
82.4 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 12.42 | 1.47 % | $ 352 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 7.87 | -0.25 % | $ 1.18 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.38 | 4.29 % | $ 164 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.02 | -0.97 % | $ 17.3 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
3.02 M | $ 1.91 | -6.62 % | $ 42.1 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.49 | -1.17 % | $ 30.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.15 | -3.71 % | $ 402 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.85 | -2.5 % | $ 70 M | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 10.9 | -0.44 % | $ 390 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.65 | -2.08 % | $ 67.1 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 73.65 | 0.84 % | $ 4.02 B | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Myomo
MYO
|
27.2 M | $ 1.09 | - | $ 45.6 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
86.1 M | $ 3.72 | 1.36 % | $ 550 M | ||
|
Electromed
ELMD
|
10.6 M | $ 38.47 | -2.09 % | $ 325 M | ||
|
Orthofix Medical
OFIX
|
401 M | $ 9.37 | -1.26 % | $ 371 M | ||
|
Butterfly Network
BFLY
|
101 M | $ 4.45 | -3.58 % | $ 1.1 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
11 M | $ 6.85 | -0.8 % | $ 207 M | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
730 M | $ 81.72 | -0.9 % | $ 11 B | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 142.42 | -0.16 % | $ 10 B | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.23 | 1.14 % | $ 6.18 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 35.7 | 0.79 % | $ 1.11 B | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 42.07 | -2.39 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 90.31 | 0.31 % | $ 3.14 B | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 86.15 | 0.23 % | $ 50.4 B | ||
|
TransMedics Group
TMDX
|
595 M | $ 67.33 | -0.73 % | $ 2.29 B |